Date	Period	Revenue/Estimate	Earnings Call
--	2027/Q1	-- / 22.500B	--
--	2026/Q1	-- / 21.500B	--
Jul 30, 2024	2025/Q1	21.164B / 19.800B	--
Jan 30, 2024	2024/Q3	20.881B / --	--
Jul 31, 2023	2024/Q1	19.313B / 17.750B	--

DatePeriodRevenue/EstimateEarnings Call

--2027/Q1-- / 22.500B--

--2026/Q1-- / 21.500B--

Jul 30, 20242025/Q121.164B / 19.800B--

Jan 30, 20242024/Q320.881B / ----

Jul 31, 20232024/Q119.313B / 17.750B--

Unlock Free Earnings Estimates

Open Account

Kissei Pharmaceutical Earnings Reports

Kissei Pharmaceutical: Confirmation letter

Nov 12 23:01 ET

Kissei Pharmaceutical: Half Year Report - Term 80 (2024/04/01 - 2025/03/31)

Nov 12 23:00 ET

Kissei Pharmaceutical: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending 2025/3

Nov 6 02:00 ET

Kissei Pharmaceutical: Consolidated Financial Results for the 2nd Quarter (Interim Period) for the Fiscal Year Ending March 31, 2025 [Japanese GAAP] (Consolidated)

Nov 5 02:30 ET

Symbol Price % Chg

Beauty Kadan Holdings

3041

417 +23.74%